4307 — Nomura Research Institute Balance Sheet
0.000.00%
Annual balance sheet for Nomura Research Institute, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 129,625 | 143,458 | 187,917 | 184,219 | 194,595 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 186,344 | 187,572 | 197,936 | 216,732 | 279,817 |
| Total Other Current Assets | |||||
| Total Current Assets | 333,645 | 349,102 | 405,178 | 419,424 | 501,060 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 76,451 | 73,991 | 69,096 | 60,662 | 74,790 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 789,655 | 838,224 | 922,773 | 928,501 | 959,794 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 298,342 | 198,247 | 214,642 | 239,482 | 273,021 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 450,295 | 439,217 | 523,241 | 494,460 | 525,889 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 339,360 | 399,007 | 399,532 | 434,041 | 433,905 |
| Total Liabilities & Shareholders' Equity | 789,655 | 838,224 | 922,773 | 928,501 | 959,794 |
| Total Common Shares Outstanding |